Table 3.
Comparative analyses – relative risk of STIs among women with versus without HIV
| STI | Studies (n) | # women with STI/# tested (%) | Relative risk (95% CI) | I2, %‡ | |
|---|---|---|---|---|---|
| HIV+* | HIV− | ||||
| Gonorrhea | 24 | 448/8777 (5.10) | 390/19 334 (2.02) | 1.89 (1.48 – 2.41) | 44 |
| Chlamydia | 25 | 437/8106 (5.39) | 793/16 889 (4.70) | 1.83 (1.13 – 2.95) | 84 |
| Trichomoniasis | 31 | 2059/12 205 (16.87) | 1666/17 604 (9.46) | 1.54 (1.35 – 1.75) | 47 |
| Mycoplasma genitalium | 9 | 230/1625 (14.15) | 197/2660 (7.41) | 1.71 (1.05 – 2.78) | 57 |
*
These estimates include only prevalence from studies that provided data on a comparable cohort of women without HIV and therefore differ from pooled prevalence values.
‡
I2 >50% reflects significant between-study heterogeneity.